Therapeutic evaluation of zinc and copper supplementation in acute diarrhea in children: double blind randomized trial.
Study Design
- Tipo de Estudo
- Randomized Controlled Trial
- Tamanho da Amostra
- 200
- População
- Children 6-59 months with acute diarrhea
- Intervenção
- Therapeutic evaluation of zinc and copper supplementation in acute diarrhea in children: double blind randomized trial. Zinc sulfate 40mg + copper sulfate 5mg daily in ORS
- Comparador
- Placebo in ORS
- Desfecho Primário
- Duration of diarrhea
- Direção do Efeito
- Neutral
- Risco de Viés
- Low
Abstract
OBJECTIVE: To test the hypothesis that daily supplementation of zinc and copper mixed with the oral rehydration solution (ORS) reduces the duration and the severity of acute diarrhea in children. METHODS: In a randomized, double blind, placebo controlled trial children aged 6 months to 59 months in an urban hospital with acute diarrhea, were assigned to receive the intervention of once daily 40 mg of zinc sulfate and 5 mg of copper sulfate dissolved in a liter of standard ORS (n = 102) or placebo (50 mg of standard ORS powder) dissolved in a liter of ORS (n = 98). RESULT: The baseline characteristics in the two groups were similar. The mean survival time (days) (SE) with diarrhea was not significantly different in the treatment (4.34 (0.2)) as compared to the placebo group (4.48 (0.2)), nor was there any difference in the median time to cure. Cure was less likely with longer duration of diarrhea prior to enrollment (P < 0.001), if the time taken for rehydration was more (P = 0.001) and if intravenous fluids were used (P = 0.03) regardless of the micronutrient supplementation. The proportion of children with diarrhea > 4 days was 46% in the placebo group with an adjusted odds ratio (OR) (95% CI) of 1.19 (1.58, 0.9; P = 0.2) as compared to 39% in the supplemented group. The most important risk factor for diarrhea > 4 days was diarrheal duration prior to enrollment with OR = 6.25 (3.7, 11.1). The supplemented group however had less severity of diarrhea with a lower proportion of children requiring unscheduled intravenous fluids (OR = 0.4; 95% CI 0.05, 2.2), with weight loss (OR = 0.7; 95% CI; 0.4, 1.3), with complications (OR = 0.15; 0.01, 1.3) and had no deaths as compared to two in the placebo group. CONCLUSIONS: This study showed that the most important predictor for duration of diarrhea in children was the severity of the disease at enrollment, and, not the supplementation. There were clinical beneficial effects of supplementation on rate of any complications and mortality. A larger trial is warranted before supplementation of micronutrients mixed with ORS are recommended for management of acute diarrhea.
Used In Evidence Reviews
Similar Papers
Advances in nutrition (Bethesda, Md.) · 2013
Discovery of human zinc deficiency: its impact on human health and disease.
The American journal of clinical nutrition · 2000
Therapeutic effects of oral zinc in acute and persistent diarrhea in children in developing countries: pooled analysis of randomized controlled trials.
The Journal of nutrition · 2003
Zinc deficiency, infectious disease and mortality in the developing world.
Food and nutrition bulletin · 2009
Preventive zinc supplementation among infants, preschoolers, and older prepubertal children.
The American journal of clinical nutrition · 1998
Therapeutic and preventive effects of zinc on serious childhood infectious diseases in developing countries.
Pediatrics · 2008